Authors
S Munshi1; D Phillips1; N Fernandez-Fuentes1; K Geyer1; K F Hoffmann1;
1 Aberystwyth University, UK
Discussion
We have previously confirmed the presence of the epigenetic mark 5-methylcytosine (5mC) in
the genome of the medically important blood fluke Schistosoma mansoni, as well as identified
the core DNA methylation machinery components DNA methyltransferase 2 (SmDNMT2) and
methyl-CpG binding domain protein (SmMBD2/3). While we demonstrated that SmDNMT2
is responsible for the establishment of this DNA modification, we did not further pursue the
role of SmMBD2/3 during schistosome epigenetic processes. MBD proteins represent the
readers of metazoan DNA methylation systems and specifically bind to methylated loci via a
conserved N-terminal 5mC-binding domain. This event catalyses the recruitment of further
co-repressors, thereby leading to a transcriptionally silent chromatin state. In S. mansoni,
previous bioinformatics-led characterisation of the metazoan MBD family suggested that
SmMBD2/3 is a functional member. Here we confirm that this schistosome protein is indeed a
functional candidate by validating binding affinity of rSmMBD2/3 to a methylated substrate
as well as demonstrating its primary nuclear localisation. A subsequent yeast-two-hybrid (Y2-H)
screen identifies the heterochromatin-associated SmCBX (S. mansoni chromobox
protein) as a putative interaction partner of SmMBD2/3 and whole mount fluorescent in situ
hybridisation (WISH) further confirms the co-expression of these proposed binding partners
throughout mesenchymal-, germ- and proliferating somatic stem cells (PSCs or neoblasts).
Interestingly, RNAi-mediated knockdown of Smmbd2/3 and Smcbx results in PSC proliferation
defects as well as reproductive deficiencies. Our data collectively suggest that SmMBD2/3
represents a functional epigenetic reader capable of binding to 5mC and its physical interaction
with the repressor SmCBX further suggests a role for these partners in heterochromatin
formation and regulation of gene expression. Additionally, the observed reductions in both
PSC proliferation and egg laying, following Smmbd2/3 and Smcbx knockdown, demonstrates
a pivotal role for these gene products in schistosome development, transmission and
immunopathology progression.